A prevention trial on cerebral infarction with dl-alpha-tocopheryl nicotinate--rationales for trial. The Alpha-Tocopheryl Nicotinate Prevention Study Group.
Hata
Y
Y
Terashi
A
A
Matsuzaki
T
T
Ohtomo
E
E
Goto
Y
Y
D000368:Aged; D000369:Aged, 80 and over; D002544:Cerebral Infarction / Q000517:prevention & control*; D002561:Cerebrovascular Disorders / Q000401:mortality; D006801:Humans; D008875:Middle Aged; D015394:Molecular Structure; D009539:Nicotinic Acids / Q000627:therapeutic use*; D012008:Recurrence; D012107:Research Design; D012307:Risk Factors; D013237:Stereoisomerism; D014810:Vitamin E / Q000031:analogs & derivatives* / Q000627:therapeutic use
D009539:Nicotinic Acids; D014810:Vitamin E; C012581:alpha-tocopheryl nicotinate